Wave Life Sciences Ltd.

WVE | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.34

+$0.08 (+2.00%)

Sep 22, 2026, 2:04 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
AMLX Amylyx Pharmaceuticals	N/A
ELVN Enliven Therapeutics	N/A
NTLA Intellia Therapeutics	N/A
ORIC ORIC Pharmaceuticals	N/A
PGEN Precigen	N/A
SYRE Spyre Therapeutics	N/A
UPB Upstream Bio	N/A
ZBIO Zenas BioPharma	N/A

Dividend Rankings ➞

Recent News

1 month ago / 247wallst.com
Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover
1 month ago / seekingalpha.com
Wave Life Sciences Ltd. (WVE) Presents at Bank of America SMID Cap Virtual Conference Transcript
1 month ago / globenewswire.com
Wave Life Sciences Announces Completion of Redomiciliation to Delaware
2 months ago / globenewswire.com
Wave Life Sciences to Present at Upcoming Investor Conferences
2 months ago / seekingalpha.com
Wave Life Sciences Ltd. (WVE) Q2 2026 Earnings Call Transcript
2 months ago / zacks.com
Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates
2 months ago / globenewswire.com
Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update
2 months ago / globenewswire.com
Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026
2 months ago / zacks.com
Wave Life Sciences (WVE) Upgraded to Strong Buy: What Does It Mean for the Stock?
3 months ago / globenewswire.com
Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation